Literature DB >> 30502552

Development and validation of sensitive and selective quantification of total and free daptomycin in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry.

Ryota Tanaka1, Yosuke Suzuki2, Koji Goto3, Norihisa Yasuda3, Hironori Koga3, Shinya Kai3, Yoshifumi Ohchi3, Yuhki Sato2, Takaaki Kitano3, Hiroki Itoh2.   

Abstract

Recently, several studies on pharmacokinetics parameters of daptomycin reported that plasma trough concentration was linked to efficacy and adverse effects, suggesting the usefulness of therapeutic drug monitoring. Although some methods for determining total daptomycin concentration using liquid chromatography coupled to tandem mass spectrometry were established previously, no sensitive quantification method for free drug concentration was established. In this study, we aimed to develop a quantitative method of measuring both total and free daptomycin concentrations using ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS), by which both trough and maximum concentrations can be measured. Plasma samples were prepared by solid phase extraction. Free fractions were obtained by ultrafiltration. The assay fulfilled the requirements of US Food and Drug Administration and the European Medicines Agency for assay validation. The methods for total and free drug showed good fit over wide ranges of 0.5-200 and 0.04-40 μg/mL, with lower limits of quantitation of 0.5 and 0.04 μg/mL, respectively. Recovery rate of free daptomycin from ultrafiltration was approximately 100%. Extraction recovery rates of total and free drug measurements ranged from 57.1 to 67.4% and 54.6 to 62.3%, while matrix effect varied between 111.9 and 118.7% and 104.0 and 127.1%, respectively. The maximum and trough concentrations of total and free daptomycin in plasma from two patients in intensive care unit were successfully determined, demonstrating the feasibility of clinical application of the novel methods for determining plasma total and free daptomycin concentrations. In conclusion, we succeeded to develop a sensitive and selective method using UPLC-MS/MS for quantitative measurement of total and free daptomycin concentrations in plasma.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C(max) and C(trough); Daptomycin; Protein binding ratio; Tandem mass spectrometry; Total and free concentration; Ultra-high performance liquid chromatography

Mesh:

Substances:

Year:  2018        PMID: 30502552     DOI: 10.1016/j.jpba.2018.11.047

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

Review 1.  Impact on Antibiotic Resistance, Therapeutic Success, and Control of Side Effects in Therapeutic Drug Monitoring (TDM) of Daptomycin: A Scoping Review.

Authors:  Carolina Osorio; Laura Garzón; Diego Jaimes; Edwin Silva; Rosa-Helena Bustos
Journal:  Antibiotics (Basel)       Date:  2021-03-05

Review 2.  Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan.

Authors:  Fumiya Ebihara; Yukihiro Hamada; Hideo Kato; Takumi Maruyama; Toshimi Kimura
Journal:  Int J Environ Res Public Health       Date:  2022-02-22       Impact factor: 3.390

3.  Quantification of 15 Antibiotics Widely Used in the Critical Care Unit with a LC-MS/MS System: An Easy Method to Perform a Daily Therapeutic Drug Monitoring.

Authors:  Catherine Feliu; Celine Konecki; Tristan Candau; Damien Vautier; Cyril Haudecoeur; Claire Gozalo; Yoann Cazaubon; Zoubir Djerada
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.